Atezolizumab-bevacizumab combination provides ‘longest survival seen’ in advanced HCC
Atezolizumab plus bevacizumab conferred the longest OS seen in a phase 3 study for treatment-naive advanced hepatocellular carcinoma, according to updated results of the IMbrave150...